Compile Data Set for Download or QSAR
Report error Found 20917 for UniProtKB: Q96D10
TargetGTPase KRas(Human)
University of California San Francisco

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50579601BDBM50579601(CHEMBL4858364 | US11453683, Example 252 | US202302...)
Affinity DataKd: <0.000200nMAssay Description:Binding affinity to KRAS (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMed
TargetGTPase KRas(Human)
University of California San Francisco

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 717622BDBM717622(US20250034173, Example 13)
Affinity DataKd: <0.00100nMAssay Description:Binding measurements were performed in parallel sets of either WT/G12D/G12C/G12V KRAS or WT K/H/N RAS proteins in GDP and/or GTPĪ³S-loaded forms.Biaco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
University of California San Francisco

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50656359BDBM50656359(CHEMBL6102214)
Affinity DataKd: <0.00100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/4/2026
Entry Details PubMed
TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 617349BDBM617349(US20230279025, Example 465)
Affinity DataIC50: 0.00100nMAssay Description:This Example illustrates that exemplary compounds of the present invention inhibit the phosphorylation of ERK downstream of KRAS G12D. AGS cells (ATC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 573400BDBM573400(US11453683, Example 259 | US20230279025, Example 4...)
Affinity DataIC50: 0.00200nMAssay Description:This Example illustrates that exemplary compounds of the present invention inhibit the phosphorylation of ERK downstream of KRAS G12D. AGS cells (ATC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50579601BDBM50579601(CHEMBL4858364 | US11453683, Example 252 | US202302...)
Affinity DataIC50: 0.00200nMAssay Description:This Example illustrates that exemplary compounds of the present invention inhibit the phosphorylation of ERK downstream of KRAS G12D. AGS cells (ATC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 617355BDBM617355(US20230279025, Example 468)
Affinity DataIC50: 0.00200nMAssay Description:This Example illustrates that exemplary compounds of the present invention inhibit the phosphorylation of ERK downstream of KRAS G12D. AGS cells (ATC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 617357BDBM617357(US20230279025, Example 469)
Affinity DataIC50: 0.00200nMAssay Description:This Example illustrates that exemplary compounds of the present invention inhibit the phosphorylation of ERK downstream of KRAS G12D. AGS cells (ATC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 617323BDBM617323(US20230279025, Example 452 | US20230279025, Exampl...)
Affinity DataIC50: 0.00200nMAssay Description:This Example illustrates that exemplary compounds of the present invention inhibit the phosphorylation of ERK downstream of KRAS G12D. AGS cells (ATC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 617363BDBM617363(US20230279025, Example 482)
Affinity DataIC50: 0.00200nMAssay Description:This Example illustrates that exemplary compounds of the present invention inhibit the phosphorylation of ERK downstream of KRAS G12D. AGS cells (ATC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetGTPase KRas(Human)
University of California San Francisco

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 717614BDBM717614(US20250034173, Example 2)
Affinity DataKd:  0.00400nMAssay Description:Binding measurements were performed in parallel sets of either WT/G12D/G12C/G12V KRAS or WT K/H/N RAS proteins in GDP and/or GTPĪ³S-loaded forms.Biaco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 617351BDBM617351(US20230279025, Example 466)
Affinity DataIC50: 0.00600nMAssay Description:This Example illustrates that exemplary compounds of the present invention inhibit the phosphorylation of ERK downstream of KRAS G12D. AGS cells (ATC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 617347BDBM617347(US20230279025, Example 464)
Affinity DataIC50: 0.00700nMAssay Description:This Example illustrates that exemplary compounds of the present invention inhibit the phosphorylation of ERK downstream of KRAS G12D. AGS cells (ATC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 617345BDBM617345(US20230279025, Example 463)
Affinity DataIC50: 0.0120nMAssay Description:This Example illustrates that exemplary compounds of the present invention inhibit the phosphorylation of ERK downstream of KRAS G12D. AGS cells (ATC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436925BDBM436925((1S,4S)-7-Amino-2'-(((2R,7aS)-2-fluorotetrahydro-1...)
Affinity DataKd:  0.0170nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas [G12C](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 717622BDBM717622(US20250034173, Example 13)
Affinity DataKd:  0.0170nMAssay Description:Binding measurements were performed in parallel sets of either WT/G12D/G12C/G12V KRAS or WT K/H/N RAS proteins in GDP and/or GTPĪ³S-loaded forms.Biaco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
US Patent

TargetGTPase KRas [G12C](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 717614BDBM717614(US20250034173, Example 2)
Affinity DataKd:  0.0190nMAssay Description:Binding measurements were performed in parallel sets of either WT/G12D/G12C/G12V KRAS or WT K/H/N RAS proteins in GDP and/or GTPĪ³S-loaded forms.Biaco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 629510BDBM629510(US20230339981, Example 198)
Affinity DataIC50: 0.0200nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436845BDBM436845(US20260022132, Compound 531a)
Affinity DataKd:  0.0200nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas [G12C](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 706700BDBM706700(US20240383922, Example 22-2)
Affinity DataIC50: 0.0200nMAssay Description:Compounds were tested for binding to GDP-loaded wild-type KRAS (WT), KRAS-G12C, KRAS-G12D, and KRAS-G12V in a 384-well assay format using a TR-FRET p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 706700BDBM706700(US20240383922, Example 22-2)
Affinity DataIC50: 0.0200nMAssay Description:Compounds were tested for binding to GDP-loaded wild-type KRAS (WT), KRAS-G12C, KRAS-G12D, and KRAS-G12V in a 384-well assay format using a TR-FRET p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
University of California San Francisco

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50656354BDBM50656354(CHEMBL6146469)
Affinity DataKd:  0.0200nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/4/2026
Entry Details PubMed
TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 629513BDBM629513(US20230339981, Example 201)
Affinity DataIC50: 0.0200nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436844BDBM436844(US20260022132, Compound 530a)
Affinity DataKd:  0.0230nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436811BDBM436811(5-((1S,4S)-7-Amino-8-cyano-2'-(((2R,7aS)-2-fluorot...)
Affinity DataKd:  0.0230nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 717620BDBM717620(US20250034173, Example 11)
Affinity DataKd:  0.0240nMAssay Description:Binding measurements were performed in parallel sets of either WT/G12D/G12C/G12V KRAS or WT K/H/N RAS proteins in GDP and/or GTPĪ³S-loaded forms.Biaco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436919BDBM436919((1S,4S)-7-Amino-4'-(2,2-bis(hydroxymethyl)azetidin...)
Affinity DataKd:  0.0260nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 617339BDBM617339(US20230279025, Example 460)
Affinity DataIC50: 0.0270nMAssay Description:This Example illustrates that exemplary compounds of the present invention inhibit the phosphorylation of ERK downstream of KRAS G12D. AGS cells (ATC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436829BDBM436829(5-((S)-7-amino-8-cyano-2'-(((2R,7aS)-2-fluorotetra...)
Affinity DataKd:  0.0270nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436832BDBM436832(5-((S)-7-amino-8-cyano-2'-(((2R,7aS)-2-fluorotetra...)
Affinity DataKd:  0.0280nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436911BDBM436911((1S,4S)-7-amino-2'-(((2R,7aS)-2-fluorotetrahydro-1...)
Affinity DataKd:  0.0290nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 706571BDBM706571(US20240383915, Example 100a)
Affinity DataIC50: 0.0300nMAssay Description:KRAS Biochemical Assayā€”BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
University of California San Francisco

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 706571BDBM706571(US20240383915, Example 100a)
Affinity DataIC50: 0.0300nMAssay Description:KRAS Biochemical Assayā€”BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50628058BDBM50628058(US20240327434, Compound 9-p1 | CHEMBL5439556)
Affinity DataKd:  0.0300nMAssay Description:Biotinylated Avi-KRAS-WT or Avi-KRAS-G12D was diluted to 20 μg/mL with 1x HBS-P+(Cat. #BR1006-71) buffer containing 100 mM MgCl2, and then flowe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436811BDBM436811(5-((1S,4S)-7-Amino-8-cyano-2'-(((2R,7aS)-2-fluorot...)
Affinity DataKd:  0.0300nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas(Human)
University of California San Francisco

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 706700BDBM706700(US20240383922, Example 22-2)
Affinity DataIC50: 0.0300nMAssay Description:Compounds were tested for binding to GDP-loaded wild-type KRAS (WT), KRAS-G12C, KRAS-G12D, and KRAS-G12V in a 384-well assay format using a TR-FRET p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12C](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 717613BDBM717613((General Method A): (8aS)-5-(6-chloro-5-cyclopropy...)
Affinity DataKd:  0.0310nMAssay Description:Binding measurements were performed in parallel sets of either WT/G12D/G12C/G12V KRAS or WT K/H/N RAS proteins in GDP and/or GTPĪ³S-loaded forms.Biaco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436845BDBM436845(US20260022132, Compound 531a)
Affinity DataKd:  0.0310nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas(Human)
University of California San Francisco

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50656355BDBM50656355(CHEMBL6149336)
Affinity DataKd:  0.0310nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/4/2026
Entry Details PubMed
TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436979BDBM436979(US20260022132, Compound 628b)
Affinity DataKd:  0.0330nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436928BDBM436928((1S,4S)-7-amino-2'-(((2R,7aS)-2-fluorotetrahydro-1...)
Affinity DataKd:  0.0330nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436898BDBM436898((1S,4S)-7-Amino-2'-(((2R,7aS)-2-fluorotetrahydro-1...)
Affinity DataKd:  0.0370nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

TargetGTPase KRas(Human)
University of California San Francisco

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 717613BDBM717613((General Method A): (8aS)-5-(6-chloro-5-cyclopropy...)
Affinity DataKd:  0.0380nMAssay Description:Binding measurements were performed in parallel sets of either WT/G12D/G12C/G12V KRAS or WT K/H/N RAS proteins in GDP and/or GTPĪ³S-loaded forms.Biaco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 706507BDBM706507(US20240383915, Example 48)
Affinity DataIC50: 0.0400nMAssay Description:KRAS Biochemical Assayā€”BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 629509BDBM629509(US20230339981, Example 197)
Affinity DataIC50: 0.0400nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
US Patent

TargetGTPase KRas(Human)
University of California San Francisco

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50656357BDBM50656357(CHEMBL6142149)
Affinity DataKd:  0.0400nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/4/2026
Entry Details PubMed
TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 629518BDBM629518(US20230339981, Example 206)
Affinity DataIC50: 0.0400nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 706670BDBM706670(US20240383922, Example 6-23)
Affinity DataIC50: 0.0400nMAssay Description:Compounds were tested for binding to GDP-loaded wild-type KRAS (WT), KRAS-G12C, KRAS-G12D, and KRAS-G12V in a 384-well assay format using a TR-FRET p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12D](Human)
Mirati Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 717614BDBM717614(US20250034173, Example 2)
Affinity DataKd:  0.0410nMAssay Description:Binding measurements were performed in parallel sets of either WT/G12D/G12C/G12V KRAS or WT K/H/N RAS proteins in GDP and/or GTPĪ³S-loaded forms.Biaco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Treeline Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 436917BDBM436917(US20260022132, Compound 590a)
Affinity DataKd:  0.0430nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details US Patent

Displayed 1 to 50 (of 20917 total ) | Next | Last >>
Jump to: